Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
Evolution of resistance is a common cause of cancer treatment failure and tumor progression. Here, the authors present a method for integrating evolutionary principles based on adaptive therapy into abiraterone therapy for metastatic castrate-resistant prostate cancer and show the positive results o...
Guardado en:
Autores principales: | Jingsong Zhang, Jessica J. Cunningham, Joel S. Brown, Robert A. Gatenby |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b379e0e807646b6afb149c07b50f8a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
por: Nikolai A. Ognerubov
Publicado: (2021) -
Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer
por: Madonna R. Peter, et al.
Publicado: (2021) -
Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
por: Faiza Naseer, et al.
Publicado: (2021) -
Clinical characteristics and outcomes for patients with non‑metastatic castration-resistant prostate cancer
por: Peter Arnold, et al.
Publicado: (2021) -
Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
por: Caffo O, et al.
Publicado: (2016)